• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从提供者角度看药物预先授权:一项前瞻性观察研究。

Medication prior authorization from the providers perspective: A prospective observational study.

机构信息

Department of Pharmacy Practice and Science, College of Pharmacy, The University of Arizona, Tucson, AZ, USA.

Department of Pharmacy Practice and Science, College of Pharmacy, The University of Arizona, Tucson, AZ, USA; Department of Biomedical Informatics, College of Health Solutions, Arizona State University, Phoenix, AZ, USA; Cambiare LLC, Phoenix, AZ, USA.

出版信息

Res Social Adm Pharm. 2019 Sep;15(9):1138-1144. doi: 10.1016/j.sapharm.2018.09.019. Epub 2018 Sep 26.

DOI:10.1016/j.sapharm.2018.09.019
PMID:30279130
Abstract

BACKGROUND

The prior authorization (PA) process for medications used by community providers requires modernization. Therefore, a deeper understanding of current state of PA from the community provider perspective is imperative to inform and modernize this managed care tool.

OBJECTIVES

Objectives of this study were to identify, analyze and categorize the issues associated with the medication PA process from provider practice perspective.

METHODS

A prospective non-experimental, cross sectional, observational study was performed using semi-structured interviews and direct observation at a convenience sample of eight primary care and medicine subspecialty group practices in Tucson, Arizona, USA. Participating practices were required to have an established medication PA process. The participant feedback from each site was analyzed using the Richards qualitative coding technique that includes descriptive coding, topic coding, and analytical coding.

RESULTS

Data were obtained from eight unique community provider offices (8 sites) at which 29 prescribers practice. The pain points identified represented five main categories: 1) information transfer gaps; 2) format disparities; 3) outdated technologies; 4) care consequences; and 5) workarounds. Prescribers and their staff suggested improvements that included real time eligibility and formulary alerts regarding PA during the e-prescribing process, accurate, up-to-date formulary data with easy-to-access alternatives, and embedded PA that is integrated with electronic medical record data. Three sites used medication PA portals such as CoverMyMeds for information gathering, but at the time of data collection, no sites used these PA portals for prospective electronic prior authorization (ePA) or the electronic process of requesting authorization from health plan payers for coverage.

CONCLUSION

The PA process for medication used by community providers is in urgent need of modernization. Pain points identified in this study could be alleviated by implementing medication ePA solutions. However, providers and their staff are largely unaware that ePA exists. Additional research in this area is needed.

摘要

背景

社区医疗机构用药的事先授权(PA)流程需要现代化。因此,从社区医疗机构提供者的角度深入了解当前 PA 的状况对于告知和现代化这一管理式医疗工具至关重要。

目的

本研究的目的是从提供者实践的角度识别、分析和分类与药物 PA 流程相关的问题。

方法

采用前瞻性非实验性、横断面、观察性研究方法,对美国亚利桑那州图森市的 8 个初级保健和医学亚专科小组实践进行半结构式访谈和直接观察。参与的实践必须有既定的药物 PA 流程。每个地点的参与者反馈使用 Richards 定性编码技术进行分析,该技术包括描述性编码、主题编码和分析性编码。

结果

数据来自美国亚利桑那州图森市的 8 个独特的社区提供者办公室(8 个地点),其中有 29 名处方医生。确定的痛点代表五个主要类别:1)信息传递差距;2)格式差异;3)过时的技术;4)护理后果;和 5)权宜之计。处方医生及其工作人员提出了一些改进建议,包括在电子处方过程中实时获取资格和处方集警报、提供准确、最新的处方集数据和易于获取的替代方案,以及嵌入式 PA 与电子病历数据集成。有三个地点使用了 CoverMyMeds 等药物 PA 门户来收集信息,但在数据收集时,没有一个地点使用这些 PA 门户进行前瞻性电子事先授权(ePA)或向健康计划支付者请求覆盖范围的电子授权流程。

结论

社区医疗机构用药的 PA 流程急需现代化。本研究中确定的痛点可以通过实施药物 ePA 解决方案来缓解。然而,提供者及其工作人员在很大程度上不知道 ePA 的存在。需要在这一领域进行更多的研究。

相似文献

1
Medication prior authorization from the providers perspective: A prospective observational study.从提供者角度看药物预先授权:一项前瞻性观察研究。
Res Social Adm Pharm. 2019 Sep;15(9):1138-1144. doi: 10.1016/j.sapharm.2018.09.019. Epub 2018 Sep 26.
2
Understanding the medication prior-authorization process: A case study of patients and clinical staff from a large rural integrated health delivery system.理解药物预先授权流程:来自大型农村综合卫生服务系统的患者和临床工作人员的案例研究。
Am J Health Syst Pharm. 2019 Mar 19;76(7):453-459. doi: 10.1093/ajhp/zxy083.
3
Perceptions of prior authorization by use of electronic prior authorization software: A survey of providers in the United States.使用电子预先授权软件对预先授权的认知:对美国提供者的调查。
J Manag Care Spec Pharm. 2022 Oct;28(10):1121-1128. doi: 10.18553/jmcp.2022.28.10.1121.
4
Impact of implementing electronic prior authorization on medication filling in an electronic health record system in a large healthcare system.在大型医疗保健系统中实施电子预先授权对电子健康记录系统中药物配给的影响。
J Am Med Inform Assoc. 2021 Sep 18;28(10):2233-2240. doi: 10.1093/jamia/ocab119.
5
Evaluation of the Fast Prior Authorization Technology Highway.快速预先授权技术高速公路评估。
J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1843-1847. doi: 10.1016/j.japh.2022.07.011. Epub 2022 Aug 9.
6
Implementation and impact assessment of integrated electronic prior authorization in an academic health system.在学术医疗体系中实施并评估综合电子预授权的效果。
J Am Pharm Assoc (2003). 2020 Jul-Aug;60(4):e93-e99. doi: 10.1016/j.japh.2020.01.012. Epub 2020 Feb 24.
7
Analysis of prior authorization success and timeliness at a community-based specialty care pharmacy.社区专科护理药房的事先授权成功率和及时性分析。
J Am Pharm Assoc (2003). 2021 Jul-Aug;61(4S):S173-S177. doi: 10.1016/j.japh.2021.01.001. Epub 2021 Feb 19.
8
Assessing the value of electronic prescribing in ambulatory care: a focus group study.评估门诊医疗中电子处方的价值:一项焦点小组研究。
Int J Med Inform. 2009 Sep;78(9):571-8. doi: 10.1016/j.ijmedinf.2009.03.007. Epub 2009 Apr 22.
9
Influence of prior authorization requirements on provider clinical decision-making.事先授权要求对提供者临床决策的影响。
Am J Manag Care. 2023 Jul;29(7):331-337. doi: 10.37765/ajmc.2023.89394.
10
Prior authorization for diabetes medications: Clinical outcomes and health disparities.糖尿病药物的预先授权:临床结果和健康差距。
Diabetes Metab Syndr. 2024 Feb;18(2):102954. doi: 10.1016/j.dsx.2024.102954. Epub 2024 Feb 1.

引用本文的文献

1
Prior Authorization of Medication and Its Influence on Provider Behavior: Latent Class Analysis.药物预先授权及其对医疗服务提供者行为的影响:潜在类别分析
J Med Internet Res. 2025 Jul 29;27:e75361. doi: 10.2196/75361.
2
Influence of prior authorization requirements on provider clinical decision-making.事先授权要求对提供者临床决策的影响。
Am J Manag Care. 2023 Jul;29(7):331-337. doi: 10.37765/ajmc.2023.89394.
3
The Impact of Electronic Health Record Interventions on Patient Access to Post-Hospital Discharge Prescriptions.电子健康记录干预措施对患者获取出院后处方的影响。
Hosp Pharm. 2023 Apr;58(2):212-218. doi: 10.1177/00185787221130689. Epub 2022 Oct 31.
4
Workarounds in Electronic Health Record Systems and the Revised Sociotechnical Electronic Health Record Workaround Analysis Framework: Scoping Review.电子健康记录系统中的工作绕过行为以及修订后的社会技术电子健康记录工作绕过分析框架:范围综述。
J Med Internet Res. 2022 Mar 15;24(3):e33046. doi: 10.2196/33046.
5
Impact of implementing electronic prior authorization on medication filling in an electronic health record system in a large healthcare system.在大型医疗保健系统中实施电子预先授权对电子健康记录系统中药物配给的影响。
J Am Med Inform Assoc. 2021 Sep 18;28(10):2233-2240. doi: 10.1093/jamia/ocab119.